Cyclo3pss Corporation
Cyclo3pss Corporation
Your view on CYPS
Overview
What the company does, where it operates, and who runs it.
About Cyclo3pss Corporation
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- William R. Stoddard
- Headquarters
- 7105 South Highland Drive, Salt Lake City, UT, US
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- William R. Stoddard
- Headquarters
- 7105 South Highland Drive, Salt Lake City, UT, US
Cyclo3pss Corporation engages in the licensing, manufacture, sale, and installation of ozone food processing products; and ozone washing and laundry sorting and counting systems for commercial and institutional laundries.
It also engages in the research and development of technologies for the sterilization and/or disinfection of certain consumer products. The company was founded in 1927 and is based in Salt Lake City, Utah.
In July 2002, the Board of Directors of Cyclo3pss determined to suspend all operations of the company immediately due to an inability to locate willing investors and to secure necessary and suitable financing.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Cyclo3pss Corporation, and the rating behind it. CYPS last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Cyclo3pss Corporation. Starting points for Cyclo3pss Corporation: EPS -$0.02, beta 21.99 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Cyclo3pss Corporation. Cyclo3pss Corporation does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Cyclo3pss Corporation. Trailing twelve-month EPS for Cyclo3pss Corporation stands at -$0.02. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Cyclo3pss Corporation. Cyclo3pss Corporation has reported as a listed company since 2010. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Cyclo3pss Corporation valued side by side against its closest peers. Cyclo3pss Corporation is measured against Medical - Diagnostics & Research peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Cyclo3pss Corporation, and how their positions are changing. At a $4,054 market value, institutional positions materially move Cyclo3pss Corporation's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Cyclo3pss Corporation executives and directors. Shares of Cyclo3pss Corporation have traded between $0.0000 and $0.0001 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Cyclo3pss Corporation. Cyclo3pss Corporation is a $4,054 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Cyclo3pss Corporation. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Cyclo3pss Corporation. Coverage tracks Cyclo3pss Corporation within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.